Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 698 31 673.8 |
96 | EP file number | EAKZ | 98 90 4545.5 |
86 | WO file number | WAKZ | PCT/US98/00449 |
97 | EP publication number | EPN | 996459 |
87 | WO publication number | WPN | 1998030231 |
54 | Designation/title | TI | VERWENDUNG VON EXEDINEN UND DEREN ANTAGONISTEN ZUR VERMINDERUNG DER LEBENSMITTELAUFNAHME |
51 | IPC main class | ICM (ICMV) | A61K 38/22 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | C07K 14/575 (2006.01), A61K 38/16 (2006.01) |
22 | DE application date | DAT | Jan 7, 1998 |
96 | EP application date | EAT | Jan 7, 1998 |
86 | WO application date | WAT | Jan 7, 1998 |
43 | Date of first publication | OT | Jul 16, 1998 |
| Date of publication of grant | PET | Sep 21, 2005 |
71/73 | Applicant/owner | INH | Amylin Pharmaceuticals, LLC, San Diego, Calif., US; AstraZeneca Pharmaceuticals LP, 19803 Wilmington, Del., US |
72 | Inventor | IN | BEELEY Robert, Nigel, Solana Beach, US; PRICKETT S., Kathryn, San Diego, US; BHAVSAR, Sunil, San Diego, US |
74 | Representative | VTR | Lorenz Seidler Gossel Rechtsanwälte Patentanwälte Partnerschaft mbB, 80538 München, DE |
10 | Published DE documents | DEPN | Original document:
DE000069831673C5 Searchable text:
DE000069831673C5 Original document:
DE000069831673T2 Searchable text:
DE000069831673T2 |
| Address for service | | Lorenz Seidler Gossel Rechtsanwälte Patentanwälte Partnerschaft mbB, 80538 München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 34905 P Jan 7, 1997
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 55404 P Aug 8, 1997
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 66029 P Nov 14, 1997
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 65442 P Nov 14, 1997
|
| Patent division in charge | | 44 |
21 | File number of protection certificate | ZAKZ | 12 2007 000 044.8 |
97 | EP language of publication | ELANG | EN - Englisch |
87 | WO language of publication | WLANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE |
| Published EP/WO documents | EPWOPN | Original document:
EP000000996459 Searchable text:
EP000000996459 Original document:
EP000000996459B1 Searchable text:
EP000000996459B1 Original document:
WO001998030231 Searchable text:
WO001998030231 |
43 | Date of first publication | EVT | Jul 16, 1998 |
| Date of the first transfer into DPMAregister | EREGT | Sep 28, 2012 |
| Date of the (most recent) update in DPMAregister | REGT | Oct 26, 2018 (Show all update days)(Hide all update days)- Oct 26, 2018; Jan 9, 2018; Aug 3, 2017; Jan 20, 2017; Jan 20, 2016; Oct 23, 2015; Jan 22, 2015; Sep 11, 2014; Aug 7, 2014; Aug 1, 2014; Feb 26, 2014; Feb 11, 2014; Jan 24, 2014; Sep 24, 2013; Aug 1, 2013; Jun 11, 2013; Jun 4, 2013; Mar 1, 2013; Feb 9, 2013; Jan 22, 2013; Nov 8, 2012
- Historical data not available for this/these date(s)
- Sep 28, 2012
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 16)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Jun 10, 2013 |
| Issue number | HN | 31 |
| Year | PJ | 2013 |
| Publication date | VT | Aug 1, 2013 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 2 |
71/73 | Applicant/owner | INH | Amylin Pharmaceuticals, LLC, San Diego, Calif., US; AstraZeneca Pharmaceuticals LP, 19803 Wilmington, Del., US |
71/73 | Previous applicant/owner | INHF | Amylin Pharmaceuticals, LLC, San Diego, Calif., US |